Paolo Tarantino: A visit to the SOLTI headquarters at ESMO24

Paolo Tarantino shared on LinkedIn:

“ No better way to kick off ESMO24 Barcelona than with a visit to the SOLTI headquarters, to get to meet the team and contribute to the Scientific Bites with a lecture on novel treatments for luminal breast cancer.

Thanks to Meritxell Bellet and SOLTI for the kind invitation!”

Source: Paolo Tarantino/LinkedIn

Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer.